kendallhealthcares.com

Mail: kendallhealthcare@gmail.com (24×7 Support for Franchise Partners)

Phone No.:  +91 9412276419, +91 9258052012, +91 9319974453

Mail: kendallhealthcare@gmail.com (24×7 Support for Franchise Partners)

K D CLAV 625 Tablet

  • Each tablet contains Amoxycillin 500mg and Clavulanate Potassium 125mg

  • Broad-spectrum antibiotic effective against bacterial infections

  • Helps treat respiratory, urinary tract, skin, and ear infections

  • Combines a penicillin antibiotic with a beta-lactamase inhibitor for enhanced efficacy

  • Clinically proven to fight resistant bacterial strains

  • Available in 10×10 tablet packaging for easy dispensing

Category:

K D CLAV 625 Tablet is a powerful combination of Amoxycillin (500mg) and Clavulanate Potassium (125mg), formulated to effectively combat a wide range of bacterial infections. This antibiotic duo works by inhibiting bacterial cell wall synthesis and protecting against enzyme-mediated resistance, ensuring superior therapeutic results.

Amoxycillin, a penicillin-type antibiotic, kills bacteria by preventing the formation of their protective cell walls, while Clavulanate Potassium acts as a beta-lactamase inhibitor, preventing bacterial resistance and enhancing the activity of Amoxycillin.

This combination is widely prescribed for the treatment of:

  • Respiratory tract infections (bronchitis, pneumonia, sinusitis)

  • Ear, nose, and throat infections

  • Urinary tract infections (UTIs)

  • Skin and soft tissue infections

  • Dental infections

K D CLAV 625 TABLET offers reliable results with broad antibacterial coverage, making it a trusted choice among healthcare professionals.

Key Benefits:

  • Broad-spectrum antibiotic activity

  • Effective against resistant bacterial strains

  • Rapid relief from infection symptoms

  • Trusted formulation for clinical effectiveness

Pack Size: 10×10 Tablets

Reviews

There are no reviews yet.

Be the first to review “K D CLAV 625 Tablet”

Your email address will not be published. Required fields are marked *

Scroll to Top